Brenda Libby Coleman

Array ( [id] => 5993529 [patent_doc_number] => 20110015182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIOIDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/837788 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21743 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015182.pdf [firstpage_image] =>[orig_patent_app_number] => 12837788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465680 [patent_doc_number] => 20120270847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIATES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/383831 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21765 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324434 [patent_doc_number] => 20120196846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'ANTI-RSV COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/383180 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26511 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097930 [patent_doc_number] => 20110003840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Pyridoindolobenzox-and thiazepine derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/803701 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6246 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003840.pdf [firstpage_image] =>[orig_patent_app_number] => 12803701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273569 [patent_doc_number] => 08637501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof' [patent_app_type] => utility [patent_app_number] => 12/828807 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102303 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12828807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608284 [patent_doc_number] => 08785450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Therapeutic compounds and compositions' [patent_app_type] => utility [patent_app_number] => 12/826630 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 1 [patent_no_of_words] => 87235 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12826630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469882 [patent_doc_number] => 08299060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid' [patent_app_type] => utility [patent_app_number] => 13/318874 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16886 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555215 [patent_doc_number] => 08329688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid' [patent_app_type] => utility [patent_app_number] => 12/824355 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16800 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12824355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550708 [patent_doc_number] => 08063041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Polymorphic Form D of bazedoxifene acetate and methods of preparing same' [patent_app_type] => utility [patent_app_number] => 12/820593 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8474 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063041.pdf [firstpage_image] =>[orig_patent_app_number] => 12820593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186687 [patent_doc_number] => 20120115852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/383908 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26195 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115852.pdf [firstpage_image] =>[orig_patent_app_number] => 13383908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140849 [patent_doc_number] => 20120094979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'THIAZOLE OR THIADIZALOE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/378809 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21632 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094979.pdf [firstpage_image] =>[orig_patent_app_number] => 13378809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543431 [patent_doc_number] => 08318722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Pyrazinooxazepine derivatives' [patent_app_type] => utility [patent_app_number] => 12/814692 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55098 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12814692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10077298 [patent_doc_number] => 09115139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Pyrazinooxazepine derivatives' [patent_app_type] => utility [patent_app_number] => 13/377918 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55104 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056149 [patent_doc_number] => 20120077802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/376368 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57687 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077802.pdf [firstpage_image] =>[orig_patent_app_number] => 13376368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266791 [patent_doc_number] => 20100298292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/784624 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 103229 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298292.pdf [firstpage_image] =>[orig_patent_app_number] => 12784624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266762 [patent_doc_number] => 20100298290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture' [patent_app_type] => utility [patent_app_number] => 12/784254 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 213592 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298290.pdf [firstpage_image] =>[orig_patent_app_number] => 12784254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547134 [patent_doc_number] => 20100222330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'New Compounds' [patent_app_type] => utility [patent_app_number] => 12/781355 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34124 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222330.pdf [firstpage_image] =>[orig_patent_app_number] => 12781355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6387925 [patent_doc_number] => 20100317619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Selective Agents for Pain Suppression' [patent_app_type] => utility [patent_app_number] => 12/779449 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 50637 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317619.pdf [firstpage_image] =>[orig_patent_app_number] => 12779449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296375 [patent_doc_number] => 20100240640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => '(THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/779014 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240640.pdf [firstpage_image] =>[orig_patent_app_number] => 12779014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598297 [patent_doc_number] => 20100292210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Novel Compounds for A-Beta-Related Pathologies' [patent_app_type] => utility [patent_app_number] => 12/777602 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49936 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292210.pdf [firstpage_image] =>[orig_patent_app_number] => 12777602 [rel_patent_id] =>[rel_patent_doc_number] =>)